Evidence map›Paper›PMID 36043965›Full record

Trial reportActa bio-medica : Atenei Parmensis2022

Use of a non-medicated plaster in chronic lumbar back pain: a randomized controlled trial.

Matteo Ricci, Alessio Mulone, Nicholas Elena, Eugenio Vecchini, Roberto Valentini, Margherita Gelmini

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Acta bio-medica : Atenei Parmensis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Matteo RicciAOUI Verona. matteo.ricci@univr.it.
Alessio MuloneAOUI Verona. alessio.mulone@gmail.com.
Nicholas Elenaa:1:{s:5:"en_US";s:11:"AOUI Verona";}. nicholas.elena1990@gmail.com.
Eugenio VecchiniAOUI Verona. eugenio.vecchini@univr.it.
Roberto ValentiniAOUI Verona. roberto.valentini@univr.it.
Margherita GelminiAOUI Verona. margherita.gelmini@hotmail.it.
University of Verona · ITCapgemini (Netherlands) · NLSt Nicholas Hospital · GBUniversity of La Verne · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe latest technology on far infrared radiations reflects the radiations emitted by the human body and induces an antalgic and anti-inflammatory effect without active ingredients. Our primary aim was to assess pain level modifications throughout the treatment period with two different types of patches, compared to a placebo. As secondary aims, we focused on addressing patients' quality of life and range of motion changes with each patch.

methodsWe assessed 54 patients with chronic lumbar back pain treated with FIT Therapy (far infrared technology) patch. Three different types of FIT Therapy patches (F4, F3, and placebo) were used according to the different power of action and patients allocated in a randomized fashion into the 3 arms of the study. Every single patient was assessed during the study using the VAS pain scale, the Roland Morris Disability Questionnaire for quality of life, and ROM for a total of 14 days.

resultsOnly the F4 patch group significantly reduced pain level at T14 compared to the placebo group (p<0.05). Meanwhile, F3 showed only a non-significant decrease compared to placebo (p=0.254). In terms of lifestyle improvements, both F3 and F4 recorded a decrease on the RMDQ of 4 and 6 points, respectively.

conclusionsCurrently, we still need further studies with longer follow-up to consider the FIT Therapy patches F4 a valid alternative as a "non-medicated pain relief", but it proved to have a role in alleviating painful symptoms and improving function in chronic lumbar back pain without adverse events.

Indexed as

Chronic PainLow Back PainBack PainHumansPain MeasurementQuality of LifeTreatment Outcome

Identifiers

PMID36043965
PMCPMC9534234
OpenAlexW4293901989

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.